Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M
Pharmaceutical maker Regeneron announced Monday it will buy genetic testing company 23andMe for $256 million following a bankruptcy auction. Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal…